Sign in
4/A

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000027

Chief Medical Officer acquired 14,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2023-03-01 Grant or award +14,200 27,130 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2023-03-01 Grant or award · Stock Option (Right to Buy) +21,500 21,500 D: show line 2 in the form
Loading xslF345X04/wf-form4a_168194087335878.xml…